Recent Stories
Keeping the Human in Medicine: Two AI CoLab Researchers on What Machines Can’t ReplaceSomeone Is Hacking the Freezers. Pay Attention.Thinking of Running in 2028? Start HereWhat the Lame Duck Session Has to Do With the Ultimate 21st-Century Power Tool: RobotsBlack October Wasn't an Attack Wave. It Was a Warning.Extreme Ownership Means Ultimate Achievement – NASA Culture Shift

The Wave

← Back to the board
Opportunity · Award

THOMAS JEFFERSON UNIVERSITY — National Institutes of Health award HHSN272201700082C

Department of Health and Human Services

NIH/NIAID viral hemorrhagic fever vaccine development funding (filovirus and Lassa fever)

At a glance

Value
$26M obligated
Awarded to
Thomas Jefferson University

Lifecycle

1 notice

Cookies

Analytics cookies help us see how the site is used. They only run if you accept. Privacy Policy

THOMAS JEFFERSON UNIVERSITY — National Institutes of Health award HHSN272201700082C — The Wave